CAROLINE APOVIAN: Open Payments
NPI 1346205606 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,022 in 9 payments from 4 companies in 2025. Trend: 2023 $4,546 · 2024 $28,600 · 2025 $17,022
Consulting: $16,718Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Currax Pharmaceuticals LLC | 5 | $6,704 |
| Neurocrine BioSciences, Inc. | 2 | $6,403 |
| PFIZER INC. | 1 | $3,200 |
| Regeneron Pharmaceuticals, Inc. | 1 | $715 |
Products named: CONTRAVE.
Industry payments across MA — which companies pay providers there.
